ML335

CAS No. 825658-06-8

ML335( ML335 | ML-335 | ML 335 | TREK-1/2 Activator )

Catalog No. M17606 CAS No. 825658-06-8

ML335 is a selective activator of both TREK-1 and TREK-2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 51 In Stock
10MG 86 In Stock
25MG 189 In Stock
50MG 312 In Stock
100MG 462 In Stock
500MG 972 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ML335
  • Note
    Research use only, not for human use.
  • Brief Description
    ML335 is a selective activator of both TREK-1 and TREK-2.
  • Description
    ML335 is a potent and selective TREK-1/2 Activator. ML335 is an agonist for OPRM1-OPRD1 heterdimerization with an EC50 of 403 nM, and selectivities vs. OPRM1, OPRD1, and HTR5A of 37, 2.7, and >99, respectively.
  • In Vitro
    Xenopus oocyte two-electrode voltage-clamp measurements show that ML335 and ML402 activate K2P2.1 and K2P10.1 but not K2P4.1 (14.3±2.7?μM, K2P2.1-ML335; 13.7±7.0?μM, K2P2.1-ML402; 5.2±0.5?μM, K2P10.1-ML335; and 5.9±1.6?μM, K2P10.1-ML402). Swapping the Lys271 equivalent between K2P2.1 and K2P4.1 results in a clear phenotype reversal for ML335 and M402 activation. ML335 and ML402 activate K2P2.1 in HEK293 cells similar to their effects in Xenopus oocytes (5.2±0.8?μM and 5.9±1.6?μM for ML335 and ML402, respectively (n≥3)).
  • In Vivo
    ——
  • Synonyms
    ML335 | ML-335 | ML 335 | TREK-1/2 Activator
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    TREK-1| TREK-2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    825658-06-8
  • Formula Weight
    373.25
  • Molecular Formula
    C15H14Cl2N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 155 mg/mL. 415.27 mM;
  • SMILES
    CS(=O)(=O)Nc1ccc(cc1)C(=O)NCc1c(cc(cc1)Cl)Cl
  • Chemical Name
    N-[(2,4-Dichlorophenyl)methyl]-4-(methanesulfonamido)benzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lolicato M, et al. K2P2.1 (TREK-1)-activator complexes reveal a cryptic selectivity filter binding site. Nature. 2017 Jul 20;547(7663):364-368.
molnova catalog
related products
  • Ziconotide Acetate

    Ziconotide is an analgesic agent and has been used to treat neuropathic and non-neuropathic pain. Ziconotide acts by binding to N-type calcium channels situated on the terminal part of primary afferent neurons of the nociceptive pathway therefore reducing synaptic transmission with potent antinociceptive effects.

  • Oxodipine

    Oxodipine, a dihydropyridine-type calcium antagonist, inhibited KCl-induced aortic contraction in rabbits and reduced cardiac force in less potent rat ventricular test-paper contractions.

  • Nilvadipine

    Nilvadipine is a calcium channel blocker (CCB) for treatment of hypertension.